Post

New HiSeq X: The Innovation Centre is considerably increasing its production capacity

The McGill University and Génome Québec Innovation Centre is pleased to announce the arrival of a new fleet of cutting edge next-generation sequencing instruments. The acquisition of five Illumina HiSeq X has vastly increased its sequencing capacity, enabling faster and more economical sequencing. For details, contact us at infoservices@genomequebec.wp.vortexdev.com.   To learn more on Illumina technologies available…

See more
Post

Congratulations to the team at Hôpital Maisonneuve-Rosemont

Government of Canada invests in research commercialization$29 million investment in two commercialization centres will accelerate Canadians’ access to innovative cancer immunotherapies and natural products.   In Montréal, the Centre for Commercialization of Cancer Immunotherapy (C3i) will receive funding of $15 million over five years to develop, translate and commercialize cancer immunotherapy. C3i, which is based in Montréal,…

See more
Post

1st International Congress on Personalized Health Care

The aim of this world première is to bring together more than 1000 specialists, researchers, academics, clinicians, managers, economists, representatives of patient associations, ethicists and experts from the pharmaceutical, biotechnology, information and communication technology (ICT) in health and medical technology fields in order to share ideas and pool resources with regards to the development of personalized medicine.…

See more
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.